INFINITI®
AutoGenomics
The company's mission is to empower clinical laboratories with an automated multiplexing MDx solution to perform molecular testing that will significantly enhance work flow, cost efficiency and turn-around time resulting in enhanced patient care.
infiniti®

The INFINITI® Analyzer is an automated, multiplexing, continuous flow, random access microarray platform that integrates all the discrete test processes such as sample handling, reagent management, hybridization, stringency and detection for the analyses of DNA into a totally self-contained system. The analyzer features a built-in confocal microscope with two lasers, a thermal stringency station and a temperature cycler for denaturing nucleic acids for allele-specific primer extension. To avoid contamination of samples or reagents, disposable pipette tips are used for each step in the assay. This eliminates the use of pumps, plumbing or tubing resulting in minimal biohazardous liquid waste.
| Name | EN | DE | FR |
INFINITI® Analyzer |
[PDF 290KB] |
[PDF 290KB] |
[PDF 290KB] |
Applications Overview |
[PDF 15KB] |
- |
[PDF 15KB] |
Applications List |
[PDF 20KB] |
- |
[PDF 20KB] |
| Name | |
The BioFilmChip® Design
|
Play |
The INFINITI® Process |
Play |
Contact
Baselstr. 55
CH-4124 Schönenbuch
Switzerland
Fon: +41 61 487 12 12
Fax: +41 61 487 12 34
info@buhlmannlabs.ch
Your local distributor
Order
About us
Job opportunities
Search
News
BUHLMANN as gold sponsor of the 5th Santorini Pharmacogenetics Conference
Functional Genomics Towards Personalized Health Care The 5th Santorini Conference will take place in Thira, Greece, on September 30th , October 1st and 2 more
Measuring of Mineralwaters and Softdrinks on Arena and Aquakem
The high expectations in speed, accuracy and precision have been achieved in an evaluation study on Arena 30 at Feldschlösschen (Carlsberg Group), Rheinfe more
BÜHLMANN Calprotectin Test introduced in Belgium
The Hartziekenhuis Hospital in Belgium introduced the BÜHLMANN Calprotectin Assay for testing of faecal samples of IBD patients. A thorough evaluation pro more
Distribution of BioPorto’s NGAL ELISA
In January 2010 BÜHLMANN starts the distribution of the innovative diagnostic products of BioPorto in Switzerland , Austria and France . more
BÜHLMANN Core | BÜHLMANN Molecular | BÜHLMANN Medical | BÜHLMANN Industrial | Customer Relations | About Us |
Contact |
